Table 1 NSCLC clinical samples used in Figs 1D–G, 2D–F.

From: MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2

Age (y) Gender
median 71 male 65
range 50–87 female 41
Histological subtype Clinical stage
adenocarcinoma 69 I 68
squamous 25 II 23
cell carcinoma   III 14
others 12 unknown 1
EGFR mutation (adenocarcinoma) Vessel cancer cell (v) invasion
exon 18 1 v (−) 70
exon 19 13 v (+) 36
exon 21 15   
wild-type 37 Pleura cancer cell (pl) invasion
unknown 3 pl (−) 70
Lymphatic cancer cell (ly) invasion pl (+) 35
ly (−) 60 unknown 1
ly (+) 45   
unknown 1